Power Law company profile

Araris Biotech

Biotech & Life Sciences · Wädenswil, Switzerland · Founded 2019 Unicorn

Building tomorrow's antibody-drug conjugates (ADCs)

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

13 investors on Araris Biotech's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 6 investors entered at this stage

VI Partners

Pureos Bioventures

Schroder Adveq

b2venture

Redalpine

4BIO Capital

Series A 4 investors entered at this stage

Wille Finance

Schroders Capital

Samsung Ventures

The Institute for Follicular Lymphoma Innovation

Series B+ 3 investors entered at this stage

Grow Cluster Wädenswil

Paul Scherrer Institut

ETH Zurich

Global footprint

Where Araris Biotech has talent and traffic

Workforce by country

4 countries with
team presence

🇨🇭 Switzerland95.8%

🇬🇧 United Kingdom4.7%

🇺🇸 United States4.7%

🇩🇪 Germany4.5%

4 countries shown

Web traffic by country

4.5K monthly visits
across markets

🇺🇸 United States53.3%

🇯🇵 Japan31.1%

🇨🇭 Switzerland15.6%

🇮🇳 India2.2%

Top 4 markets shown

Patent intelligence

$1M patent portfolio · 8 active families

Estimated portfolio value

$1M

0.09% of valuation · 1907.1× smaller than top peer Ablynx ($2B)

8 active patent families

Where Araris Biotech innovates Molecular biologyAntiendomysial antibodiesPharmaceutical drugCamptothecinDisease

Where Araris Biotech concentrates vs peers

Each axis is a top-10 topic across Araris Biotech and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Araris Biotech

An AI-synthesized read of the highest-engagement posts about Araris Biotech on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Araris Biotech on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles